share_log

Citigroup Maintains Neutral on Pfizer, Lowers Price Target to $29

Benzinga ·  Jan 28 12:27  · Ratings

Citigroup analyst Andrew Baum maintains Pfizer (NYSE:PFE) with a Neutral and lowers the price target from $30 to $29.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 411

Recommended

Write a comment